SCHEMBL17004434

SCHEMBL17004434

O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccccc3C3=CCC4C5CCC4C3C5)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 16/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2386190 0.88 BCL2 (0.59) BCL2
SCHEMBL2387202 0.86 BCL2 (0.58) BCL2
SCHEMBL2385441 0.86 BCL2 (0.58) BCL2
SCHEMBL2385436 0.86 BCL2 (0.58) BCL2
SCHEMBL2387213 0.86 BCL2 (0.58) BCL2
SCHEMBL2385432 0.86 BCL2 (0.58) BCL2
SCHEMBL2386520 0.84 BCL2 (0.60) BCL2
SCHEMBL2387292 0.83 BCL2 (0.58) BCL2
SCHEMBL2386187 0.83 BCL2 (0.59) BCL2
SCHEMBL2384509 0.82 BCL2 (0.62) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2550258-B1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE INC (US) 2015-08-19 — — EP claimed
Send feedback